<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02553954</url>
  </required_header>
  <id_info>
    <org_study_id>SkinAge-1306</org_study_id>
    <secondary_id>2013-A01793-42</secondary_id>
    <nct_id>NCT02553954</nct_id>
  </id_info>
  <brief_title>Molecular Mechanisms of Senescence Predisposing to Cancer : Exploratory Analysis on Healthy Tissues (SkinAge).</brief_title>
  <official_title>Molecular Mechanisms of Senescence Predisposing to Cancer : Exploratory Analysis on Healthy Tissues Collected for Two Age Groups.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Oscar Lambret</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut de Biologie de Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Oscar Lambret</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidemiological data show that the incidence of carcinoma, the most common cancer, is&#xD;
      strongly linked to the age. Non Melanoma Skin Carcinomas (NMSCs) (the most frequent cancers&#xD;
      in the elderly population) derive from keratinocytes of the basal layer of the epidermis,&#xD;
      from differentiated keratinocytes of the more superficial layers or from stem cells of hair&#xD;
      follicles. Unlike NMSCs, soft-tissue sarcomas, including those deriving from dermal&#xD;
      fibroblasts, are very rare (less than 1% of all cancers). Our overall purpose is to decipher&#xD;
      the molecular pathways activated during the aging of these tissues that may explain why they&#xD;
      have a so different propensity to undergo a malignant transformation. Given that senescent&#xD;
      cells accumulate in the dermis and epidermis with age, we will constitute two groups : &quot;young&#xD;
      skin&quot; that we arbitrarily limit to the range ≥ 18 and ≤ 40 and &quot;aged skin&quot; ≥ 55.&#xD;
&#xD;
      Thus the main objective of our study is to search within 2 age groups (≥ 18 and ≤ 40 years&#xD;
      and ≥ 55 years) the expression of senescence markers on healthy skin tissue.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Information and obtaining informed consent.&#xD;
&#xD;
        -  Collection of clinical data.&#xD;
&#xD;
        -  Collection of two samples of healthy skin tissue, without disfigurement, during an&#xD;
           intervention under general anesthesia for the treatment of a sarcoma.&#xD;
&#xD;
        -  Freezing samples of healthy skin tissue in liquid nitrogen within 10 minutes after&#xD;
           collection.&#xD;
&#xD;
        -  Transfer of the samples to the laboratory of anatomopathology.&#xD;
&#xD;
        -  Preparation of the healthy skin samples by the laboratory of anatomopathology.&#xD;
&#xD;
        -  Transfer of the conditioned samples to the Institut de Biologie de Lille for analysis.&#xD;
&#xD;
        -  Control of the aesthetic appearance during the postoperative consultation.&#xD;
&#xD;
        -  Destruction of the samples at the end of analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 7, 2014</start_date>
  <completion_date type="Actual">April 2020</completion_date>
  <primary_completion_date type="Actual">April 16, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Expression of senescence markers in healthy skin tissues collected for the two age groups.</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Research of emerging cells in the skin tissue of the subjects of the two age groups via the expression of the Protease-Activated Receptor-1 (PAR-1).</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of different types of DNA damage (single and double strand breaks) in the keratinocytes and fibroblasts of the skin tissues of the two age groups.</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>Baseline</time_frame>
    <description>Postoperative complications up to 30 days after surgery according to the Clavien-Dindo classification (2009), according to the NCI-CTCAE v4.0 beyond this deadline.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Sarcoma</condition>
  <arm_group>
    <arm_group_label>Collection of healthy skin tissue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Collection of healthy skin tissue</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Collection of healthy skin tissue</intervention_name>
    <description>Collection of two samples of healthy skin tissue, without disfigurement, during an intervention under general anesthesia for the treatment of a benign or malignant tumor.</description>
    <arm_group_label>Collection of healthy skin tissue</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with an operable sarcoma&#xD;
&#xD;
          -  Requiring a surgical operation under general anesthesia at the Oscar Lambret Centre&#xD;
&#xD;
          -  Age ≥ 18 ans, belonging to one of the two following age groups : [ ≥ 18 and ≤ 40&#xD;
             years] and [ ≥ 55 years]&#xD;
&#xD;
          -  Patient having a social security scheme&#xD;
&#xD;
          -  Patient having signed an informed consent form for the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient aged under 18 or between 41 and 54&#xD;
&#xD;
          -  Location of the tumor on the face, neck or neckline&#xD;
&#xD;
          -  Patient with a skin tumor&#xD;
&#xD;
          -  Tumor-induced cutaneous fistula making suspect a tumor invasion of the skin&#xD;
&#xD;
          -  Patient with a chronic skin disease&#xD;
&#xD;
          -  Collection in an area already treated by surgery, radiotherapy or brachytherapy&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Patient under guardianship or tutorship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas PENEL, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Centre Oscar Lambret</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olivier PLUQUET</last_name>
    <role>Study Director</role>
    <affiliation>Institut de Biologie de Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 17, 2015</study_first_submitted>
  <study_first_submitted_qc>September 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2015</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mechanisms of Senescence</keyword>
  <keyword>Senescence markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

